A

Aeglea Biotherapeutics (AGLE)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Aeglea Biotherapeutics (AGLE)

Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology company. It is focused on human enzyme therapeutics to treat people with rare metabolic diseases. Its lead product candidate is pegzilarginase, which is a recombinant human arginase 1 tha... Read more

  • 0.45
  • 0.45
  • 0.41
  • 4.83
  • -59.8%
  • 6M
  • 945.00
  • 2.08M
  • 31M
  • 0.37
  • -88.3%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.